Skip to main content

Hidradenitis Suppurativa

Hidradenitis Suppurativa

Featured

Podcast
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
News
Patients with hidradenitis suppurativa (HS) have an increased risk of developing inflammatory arthritis, according to a recent study published in Dermatology.
Derm Q&A
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
News
A study published in the Journal of Allergy and Clinical Immunology found that hidradenitis suppurativa tunnels are a source of inflammation, often causing significant burden in patients with the dise
News
An international group of 31 experts in hidradenitis suppurativa reached consensus agreements on the definitions for morphological features of HS lesions, clarifying terms frequently evaluated in HS c
Back to Top